BioAtla
BCAB
BCAB
97 hedge funds and large institutions have $128M invested in BioAtla in 2022 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
3.48% less ownership
Funds ownership: 74.73% → 71.25% (-3.5%)
75% less capital invested
Capital invested by funds: $518M → $128M (-$391M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
97
Holding in Top 10
–
Calls
$596K
Puts
$436K
Top Buyers
| 1 | +$4.67M | |
| 2 | +$4.13M | |
| 3 | +$4.01M | |
| 4 |
Renaissance Technologies
New York
|
+$2.33M |
| 5 |
Two Sigma Investments
New York
|
+$1.93M |
Top Sellers
| 1 | -$17M | |
| 2 | -$13M | |
| 3 | -$11.6M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$8.76M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.01M |